| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/06/1992 | EP0483219A1 Enhancement of musculature in animals |
| 05/06/1992 | EP0472588A4 Composition and method for reducing gastro-intestinal distress due to alpha-d-galactoside-linked/containing sugars |
| 05/06/1992 | EP0313654B1 Drug for prophylaxis and treatment of hepatopathy |
| 05/06/1992 | EP0248062B1 Medicaments |
| 05/06/1992 | CN1060871A Novel onco-fetal gene, gene product and uses therefor |
| 05/06/1992 | CN1060851A Prolonged release preparation and polymers thereof |
| 05/06/1992 | CN1060848A Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising same |
| 05/06/1992 | CN1060788A Synergism of tnf and il-4 |
| 05/05/1992 | US5110912 Purification of il-2-containing hybrid compounds |
| 05/05/1992 | US5110909 Both covalent and ionic bonding with ligand attached to polymer |
| 05/05/1992 | US5110908 Haemophilus influenzae peptides and proteins |
| 05/05/1992 | US5110907 Factor viii complex purification using heparin affinity chromatography |
| 05/05/1992 | US5110906 Derivatives of soluble T-4 |
| 05/05/1992 | US5110904 Lhrh analogs |
| 05/05/1992 | US5110799 Inhibition of viral ribonucleotide reductase |
| 05/05/1992 | US5110798 Purine derivatives having pharmacological action |
| 05/05/1992 | US5110797 Neurotropic agents |
| 05/05/1992 | US5110796 Prophylactic and therapeutic agents for cataracts |
| 05/05/1992 | US5110795 Methods and compositions for the treatment of inflammatory bowel diseases and conditions |
| 05/05/1992 | US5110738 Genetic engineering; hybridomas of melanoma and spleen cells |
| 05/05/1992 | US5110730 Human tissue factor related DNA segments |
| 05/05/1992 | US5110604 Wound healing |
| 05/05/1992 | US5110595 Implant preparations containing bioactive macromolecule for sustained delivery |
| 05/05/1992 | US5110590 Use of a solution of alpha-chymotrypsin |
| 05/05/1992 | US5110348 Glycine compounds and herbicidal compositions thereof |
| 05/05/1992 | CA1300313C2 Amino acid derivatives |
| 05/05/1992 | CA1300011C Encapsulation of trh or its analog |
| 05/05/1992 | CA1300010C Hepatocyte growth factor |
| 05/05/1992 | CA1300009C Lhrh analog formulations |
| 05/05/1992 | CA1300008C Acid lyophilised pharmaceutical formulation of tissue plasminogen activator |
| 05/03/1992 | WO1992007870A1 Platelet aggregation inhibitors |
| 05/03/1992 | CA2488792A1 Antisense oligonucleotides for treatment of cancer |
| 05/03/1992 | CA2092315A1 Platelet aggregation inhibitors |
| 05/03/1992 | CA2054667A1 Cyclopeptides |
| 05/02/1992 | CA2054830A1 Method for producing a new medicine for both treating and preventing peptic ulcer diseases and gastritis, and it's formulated medicines |
| 05/01/1992 | WO1992008731A2 T-cadherin adhesion molecule |
| 05/01/1992 | WO1992007581A1 Methods and compositions for suppressing allograft rejection in mammals |
| 05/01/1992 | CA2095115A1 T-cadherin adhesion molecule |
| 05/01/1992 | CA2054228A1 Muramyldipeptide derivatives and influenza vaccine comprising the derivatives |
| 04/30/1992 | WO1994007913A1 Peptide antagonists of sh2 binding and therapeutic uses thereof |
| 04/30/1992 | WO1992007267A1 A synthetic peptide and its uses |
| 04/30/1992 | WO1992007254A2 Use of disulphide bidged substances |
| 04/30/1992 | WO1992007084A1 Purified cdw52-specific antibodies |
| 04/30/1992 | WO1992007083A1 Antibodies against the urokinase receptor and their use |
| 04/30/1992 | WO1992007076A1 Modified human tnfalpha (tumor necrosis factor alpha) receptor |
| 04/30/1992 | WO1992007074A1 Polypeptide of a growth factor receptor family, application in the diagnosis and treatment of myeloproliferative diseases |
| 04/30/1992 | WO1992007073A1 Osteogenic peptides |
| 04/30/1992 | WO1992007065A1 Modified ribozymes |
| 04/30/1992 | WO1992007005A1 Platelet adhesion inhibitor |
| 04/30/1992 | WO1992007004A1 Osteogenic protein |
| 04/30/1992 | WO1992007002A1 A collagen binding protein as well as its preparation |
| 04/30/1992 | WO1992007000A1 Pharmaceutical composition for the treatment or prevention of a malignant tumor |
| 04/30/1992 | WO1992006996A1 Peptides containing substituted 1,4-diamines as transition-state inserts |
| 04/30/1992 | WO1992006989A1 Varicella-zoster virus antigen |
| 04/30/1992 | WO1992006988A1 Method for the production of catalytic rna in bacteria |
| 04/30/1992 | WO1992006713A1 Pharmaceutical composition containing an ace inhibitor and an inhibitor of thromboxane a2 activity for treating nephropathies |
| 04/30/1992 | WO1992006711A1 Blood coagulation protein antagonists and uses therefor |
| 04/30/1992 | WO1992006708A1 Treatment of autoimmune diseases by oral administration of autoantigens |
| 04/30/1992 | WO1992006707A1 Methods and compositions for the treatment of cell proliferation disorders |
| 04/30/1992 | WO1992006706A1 Treatment of inflammation |
| 04/30/1992 | WO1992006705A1 Heparin binding mitogen with homology to epidermal growth factor (egf) |
| 04/30/1992 | WO1992006704A1 Method of treating or preventing type 1 diabetes by oral administration of insulin |
| 04/30/1992 | WO1992006702A1 A method for transplanting cells into the brain and therapeutic uses therefor |
| 04/30/1992 | WO1992006697A1 Anti-inflammatory composition |
| 04/30/1992 | WO1992006667A1 External preparation for skin |
| 04/30/1992 | WO1991019725A3 Heterocyclic anthracyclione and anthracycline analogs |
| 04/30/1992 | WO1991018866A3 1,4-diamino-2,3-dihydroxybutanes |
| 04/30/1992 | CA2094372A1 Blood coagulation protein antagonists and uses therefor |
| 04/30/1992 | CA2094045A1 Heparin binding mitogen with egf homology |
| 04/30/1992 | CA2071854A1 Method for the production of catalytic rna in bacteria |
| 04/29/1992 | EP0483113A2 A method of producing an enzymatically active polypeptide analog of human Cu/Zn SOD |
| 04/29/1992 | EP0483086A2 Process for the preparation of drugs for the treatment of hepatitis B, and drugs so obtained |
| 04/29/1992 | EP0482966A2 Stabilised derivatives of fragments of hirudin, their preparation and pharmaceutical preparations |
| 04/29/1992 | EP0482649A2 CM-chitin derivatives and use thereof |
| 04/29/1992 | EP0482623A2 Smooth muscle mitogen |
| 04/29/1992 | EP0482598A2 Peptide analog of human TSH receptor affective against autoimmune hyperthyroidism |
| 04/29/1992 | EP0482539A2 Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising the same |
| 04/29/1992 | EP0482498A2 Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor |
| 04/29/1992 | EP0482345A1 Nutritive composition and process for preparing the same |
| 04/29/1992 | EP0482213A1 Antineoplastic agent |
| 04/29/1992 | EP0482185A1 Cell internalizable conjugates and complexes including intracellularly cleavable moieties |
| 04/29/1992 | EP0482176A1 Monoclonal antibodies specific for toxin b of clostridium difficile |
| 04/29/1992 | EP0482172A1 Anti-tumor agents having reduced toxicity on the basis of cytostatic agents and xanthogenates |
| 04/29/1992 | EP0482144A1 Method for the recombinant production of hiridins and hirudin-like polypeptides |
| 04/29/1992 | EP0482133A1 Use of lactoferrin to counter the toxic effects of endotoxins. |
| 04/29/1992 | EP0482124A1 Somatotropin analogs. |
| 04/29/1992 | EP0482097A1 Surfactant compositions and methods |
| 04/29/1992 | EP0482086A1 Antagonists of gm-csf derived from the carboxyl terminus |
| 04/29/1992 | EP0482069A1 Combinations and methods for treating or preventing thrombotic diseases |
| 04/29/1992 | EP0482018A1 Toxin uses |
| 04/29/1992 | EP0092574B1 Oligonucleotide therapeutic agent and methods of making same |
| 04/28/1992 | US5109123 Alteration of ability of soluble CD4 fragments to bind HIV |
| 04/28/1992 | US5109120 Extended blood circulation life |
| 04/28/1992 | US5109119 Concentrated and equilibrated in polyoxyethylene glycol solution |
| 04/28/1992 | US5109118 Bonded to lecithin via a chemical linkage; no side effects; anticancer antidiabetic agents |
| 04/28/1992 | US5109116 Plancenta extract; composed of oligosaccharide and protein |
| 04/28/1992 | US5109115 Monoclonal antibody specific for bombesin |
| 04/28/1992 | US5109113 Membrane anchor fusion polypeptides |
| 04/28/1992 | US5109111 Corticotropin releasign factor |
| 04/28/1992 | US5109016 Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions |